EUCTR2008-001853-17-BE进行中（未招募）不适用
Invloed van behandeling met infliximab op immuuncellen in het bloed van patiënten met spondyloartritis
niversity Hospital Ghent0 个研究点开始时间: 2008年5月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patiënten met spondyloartritis die 18 jaar of ouder zijn, die van het mannelijk of vrouwelijk geslacht zijn, die zich aanmelden op de dienst reumatologie en waarbij, omwille van klinisch therapeutische redenen, behandeling met infliximab wordt opgestart door de behandelende arts.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Alle patiënten die niet aan de inclusiecriteria beantwoorden, worden uit de studie geëxcludeerd.
研究者
相似试验
已完成
不适用
oss of response to infliximab in patients with intractable ulcerative colitis: Clinical features and outcomes.ulcerative colitisJPRN-UMIN000016640Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine40
招募中
1 期
The iCaD StudyImmune checkpoint inhibitor related colitisCTIS2022-503026-12-00Odense University Hospital225
进行中（未招募）
1 期
BackToBasic: The effect of Infliximab in patients with chronic low back pain and vertebral oedema on MRI scan.A randomized, double blind, placebo-controlled, multicenter trialon-specific chronic low back pain of more than 6 months duration. We will only investigate those who have vertebral end-plate chanages(Modic changes) on MRI.MedDRA version: 20.0Level: LLTClassification code 10008837Term: Chronic back painSystem Organ Class: 100000004859EUCTR2017-004861-29-NOFOU, Nevroklinikken, Oslo University Hospital -Ullevål126
已完成
不适用
Study for predictors of response to infliximab therapy for ulcerative colitislcerative colitisJPRN-UMIN000007256Kanagawa Crohn Disease Treatment Study Group50
尚未招募
不适用
Induction of the remission by use of infliximab in RARheumatoid arthritisJPRN-UMIN000003344Division of Rheumatology, Department of Internal Medicine, Kanazawa University Hospital20